Yogurt’s Role In The Early Development Of The CRISPR Gene Editing System

Yogurt’s Role In The Early Development Of The CRISPR Gene Editing System

Eugene Koonin’s dabbling with Streptococcus thermophilus eventually led him to discover CRISPR before CRISPR was a thing. An evolutionary biologist and senior investigator in the National Library of Medicine’s National Center for Biotechnology Information (NCBI), Koonin hypothesized in 2005 that “spacer DNA” in the clustered regularly interspaced short palindromic repeats (CRISPR) loci of bacteria and … Read more

In Conversation: Dr. Bradley Harding Discusses DNA-Computing

In Conversation: Dr. Bradley Harding Discusses DNA-Computing

Dr. Bradley Harding is a scientist specializing in DNA-based computing. His research, recently published in the prestigious journal Nano Letters, holds the potential to advance the field reusable biodevices controlled by logical operations. Dr. Harding’s research was co-supervised by the University of the Sunshine Coast’s Dr Joanne Macdonald and Dr Nina Pollak, assisted by collaborator … Read more

This Chinese Cloud Company To Expand Its Clinical Trails Software With $176 Million VC Financing

This Chinese Cloud Company To Expand Its Clinical Trails Software With $176 Million VC Financing

Taimei Technology of Shanghai completed a $176 million financing to support its AI cloud-based suite of programs for clinical trials and drug safety. The company’s SAAS platform enables clinical research collaboration between sponsors, sites, CROs, patients, regulatory agencies and third-party providers. Its latest funding was co-led by Tencent Holdings, GL Ventures (a Hillhouse subsidiary), and YF Capital, … Read more

This Chinese Startup Completes Series B Financing For Oncolytic Virus Development

This Chinese Startup Completes Series B Financing For Oncolytic Virus Development

Immvira Group Company announced this week the completion of series B financing for $58 million. The biotechnology startup focuses on the development of new generation oncolytic viruses as potential cancer therapeutics. Immvirva attracted a number of biotech investors. This round of financing was led by Huagai Capital, with participation by Apricot Capital, Cowin Capital. The funds … Read more

Researchers Generate Complete Human X Chromosome Sequence

Researchers Generate Complete Human X Chromosome Sequence

Since sequencing the first whole human genome in 2003, scientists have failed to identify small gaps scattered among the 23 pairs of chromosomes. Sometimes called dark genes, these genes have limited scientific understanding of genetics. Short-read sequencers make errors interpreting dark genes because they contain long, highly repetitive stretches of DNA that produce errors during … Read more

Amid The Turmoil Of 2020, This Company Was The First To Treat Patients With A Genome Editing Therapy

Amid The Turmoil Of 2020, This Company Was The First To Treat Patients With A Genome Editing Therapy

In March, Allergan plc and Editas Medicine, Inc. announced the treatment of the first patient in the BRILLIANCE clinical trial of AGN-151587 (EDIT-101) at Oregon Health & Science University (OHSU) Casey Eye Institute, an academic eye center. Scientists say that the gene editing tool, CRISPR, used in this trail is the first time CRISPR has … Read more

IPO: Grail, Inc Aims To Bring Liquid Biopsy To Healthcare

IPO: Grail, Inc Aims To Bring Liquid Biopsy To Healthcare

U.S.-based cancer testing startup Grail Inc has filed for a U.S. initial public offering (IPO) to complete the commercialization of its population-scale multi-cancer early detection testing capability based on a technology called liquid biopsy. Grail was spun out of gene sequencing company Illumina Inc in 2016, with investments from ARCH Venture Partners, Sutter Hill Ventures … Read more

Categories IPO